Global Muscle Stimulator Market By Product Type(Interferential, Burst Mode Alternating Current), By Modality, By Application, By End-Use, By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2022-2032.

In 2022, the Global Muscle Stimulator Market size is expected to be worth around USD 1156.03 million by 2032 from USD 730.3 million in 2022, growing at a CAGR of 4.7% during the forecast period 2022 to 2032.

An electric muscle stimulator is a device that emits electrical pulses to stimulate muscles. It is commonly used in physical therapy and rehabilitation. Muscle stimulators can be used to relieve pain, increase blood circulation, and promote healing.

The key drivers of this market are the increasing popularity of muscle stimulators among physiotherapists, the emphasis on pain management therapies in sports medicine, as well as technological advances in medical equipment. Market growth is also expected to be driven by the surging incidence of musculoskeletal diseases among individuals.

Global Muscle Stimulator Market Scope:

Product Type Analysis

Based on Products, the transcutaneous electrical nerve stimulation market sub-segment accounted for the largest share in 2021. This sub-segment is expected to continue its position dominance over the forecast period. Market growth is presently being driven by the increasing prevalence of arthritis and sports injuries.

The Centers for Disease Control and Prevention reported that 54.4 million adults were diagnosed with arthritis in the United States. This number is expected to increase to 78 million by 2040. This growth is expected to be driven by the increasing prevalence of arthritis.

The fastest-growing sub-segment over this forecast timeline is anticipated to be the Neuromuscular Electrical Stimulation (NMES) sub-segment. This type of muscle stimulator can be used to restore or substitute motor functions for patients who have suffered from motor neuron damage in the upper motor neurons following a stroke or Spinal Cord Injuries (SCI).

According to the National Spinal Cord Injury Statistical Center’s 2019 factsheet, there are approximately 17.730 cases of SCI in the U.S. and 291,000 people currently suffering from the condition. The demand for NMES is expected to increase over the forecast period as SCIs become a more common occurrence.

Modality Analysis

On the basis of Mode, this market can be divided into three segments – handheld, portable, or tabletop. The ‘Portable Devices’ sub-segment accounted for the majority of revenue share in 2022, with a projected CAGR of 5.7% expected over the forecast 2022-2032.

The most common uses of advanced devices and portable muscle stimulators are to prevent muscle atrophy, relax muscle spasms, manage chronic pain due to arthritis, increase blood circulation, and manage chronic pain. Many market leaders offer a variety of innovative stimulators in this segment. NeuroMetrix Inc., for instance, offers a portable pain relief kit.

This TENS unit fits like a brace and provides pain relief. JetStream, which can be used at home is offered by Zynex Inc. OMRON Corporation currently offers a portable, small-sized electrotherapy TENS device for sore and aching muscles.

The higher the adoption rates for these types of devices over the forecast period will have a positive influence on the global muscle stimulator market.

Application Analysis

With respect to ‘Application’, this market is classified into pain management, neurological disorder, musculoskeletal disease, and others. The ‘Pain Management application accounted for 53.7% of the market’s revenue in 2021.

This industry is expected to grow due to the increasing usage of muscle stimulators to manage chronic and acute pain as well as a spike in the prominence of arthritis.

This market is expected to expand at a rapid pace due to booming geriatric populations that are more prone to suffer from muscle pain and increasing levels of chronic pain. According to the CDC, 20.4% of the United States suffered from chronic pain in 2016. In America, 0.8% had severe chronic pain.

Similar statistics were found in many Asian and European countries. Market growth over the forecast period is expected to be driven by a growing incidence of chronic pain.

This growth is attributable to the rising prevalence of chronic pain among people, which would boost the demand for advanced devices and wearables offering vital therapeutic benefits.

End-Use Analysis

This market’s end-use segmentation is as follows – Ambulatory Surgical Centers (ASCs), Hospitals, Specialty Clinics, Home Care, as well as Other End-Users. In 2021, the ‘Specialty Clinics’ sub-segment had the highest market share and is anticipated to index the highest expected CAGR of 6.1% over the forecast period.

The segment’s growth is driven by the increasing preference and usage of stimulators by physiotherapists in comparison to manual techniques.

However, the primary factors expected to drive the market growth are increasing patient visits to seek stimulation therapies and the affordability of these therapies at physiotherapy centers. The segment growth is also expected to be driven by the provision of reimbursements to patients seeking these therapies.

Market  Trends:

Patients with COVID-19 (C-19), who have spent a longer duration of time in an ICU are often more difficult to rehab. They suffer from a variety of physiological disabilities, including paralysis of various muscle functions. About 40% of patients who are admitted to the ICU have paralysis in their skeletal or respiratory muscles.

This condition is commonly known as ICUAW (Impaired Critical Unit). This makes it very difficult to walk, engage in daily activities, and return to normal daily living. Neuromuscular Stimulation (NMES), is a technique that uses small electrical impulses in the skeletal muscles to cause contractions in patients who are unable or unwilling to engage them. NMES has many benefits, including improved strength and muscle function as well as better blood flow and reduced edema.

These simulators are also used to manage the pain in COVID-19 sufferers. This sub-segment is expected to continue to expand on account of the prevalence of this pandemic.

Transcutaneous electrical nerve stimulation is one of the most popular forms of electrical stimulation for pain management. It provides temporary relief. For pain relief from a wide range of conditions such as back pain, etc., electrothermal therapy and electrical nerve stimulation can be used. Intervertebral disc issues can cause lower back pain. Intradiscal Electrothermal Therapy (IDET), is one form of this treatment.

This sub-segment also continues to grow due to the increasing prevalence of conditions such as arthritis, back pain, and migraines. The WHO report, 2021, indicates that rheumatoid arthritis is more prevalent in developed countries than in developing nations. It is also more common in women. Globally, more than 23 million people suffer from rheumatoid arthritis. 1 in 100 individuals will develop it. If left untreated, this can lead to serious disability. Due to a booming global geriatric population, it is predicted that these numbers will likely double by 2030.

Key Market Segments:

By Product Type

• Neuromuscular Electrical Stimulation
• Functional Electrical Stimulation
• Transcutaneous Electrical Nerve Stimulation
• Interferential
• Burst Mode Alternating Current
• Micro Current Electrical Neuromuscular Stimulator
• Other Product Types

By Modality

• Handheld
• Portable
• Table Top Devices
• By Application
• Pain Management
• Neurological Disorder
• Musculoskeletal Disorder
• Other Applications

By End-User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Home Care
• Other End-Users

Market Dynamics:

One advantage of using an EMS machine is that it can help users target specific muscle groups. If they’re trying to focus on their biceps, for example, the settings on the EMS machine can be adjusted to target that specific area. Another advantage of using an EMS machine is that it can help users save time at the gym. Instead of spending 30 minutes doing a traditional weight-lifting routine, a user can use the EMS machine for a shorter, yet more targeted workout.

There are also some disadvantages to using an EMS machine. One downside is that they can be expensive; a high-quality EMS machine can cost several hundred dollars. Poor body posture, poor diet, and inactivity are all common causes of musculoskeletal disorders.

According to the National Center for Biotechnology Information’s (NCBI) data, musculoskeletal diseases affected around 41.0% of Great Britain in 2016. The American Academy of Orthopedic Surgeons reports that around 126.6 million Americans were affected by musculoskeletal disorders in 2016.

In the future, market growth is anticipated to be driven by technologically advanced products like wearable muscle stimulator devices. PowerDot, a small and lightweight muscle stimulator that was launched in 2017, is designed to prevent muscle tightening and soreness.

This market is registering an increase in the demand for portable and wireless muscle stimulators that are compatible with smartphones. This is expected to have an exponentially significant influence on the market growth opportunities for industry players.

This market is also expanding because of an increasing preference among physiotherapists to use muscle stimulators. As they are less time-consuming and more efficient, physiotherapists are making the transition from manual methods to using muscle stimulators in their clinical and home care practices. Growth is also expected to be fueled by growing incidences of tendon tears (ACL, PCL, etc.), hip flexor strain, and hamstring strain among sports players who then require muscle stimulation therapy.

However, customers are encouraged to choose cheaper alternatives such as yoga and acupuncture instead. Yoga and acupuncture are popular in developing countries like India and China due to their convenience and flexibility.

The increased use of alternative therapies is also due to a lack of guidelines regarding the use of muscle stimulators. Market growth could potentially be slowed down by this increased adoption of alternative therapies by patients.

COVID-19 Impact On Muscle stimulator Market:

Coronavirus (COVID-19), which was first identified in China’s Hubei Province of Wuhan, in December, 2019. The virus responsible for the disease, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted among people.

Trade restrictions across countries prevented the flow of pharmaceutical ingredients and products, thus disrupting supply chains. COVID-19, has flu-like symptoms, including coughing, fever, and difficulty breathing. Due to its impact on clinical trials, and the hindering of drug supply to patients, COVID-19 has had a devastating effect on the market for muscle stimulators. The COVID-19 pandemic brought about a dramatic decline in various outpatient treatments and tests, as well as surgical treatments.

This led to a decline in revenue for many market players in the muscle stimulator landscape. For example, Neurometrix Inc. experienced a decrease of 20% in net sales in FY2019-2020.

This drop was due in large part to the cancellation of elective procedures and treatments in America as a consequence of the COVID-19 pandemic. Additionally, because of this situation, numerous elective procedures were postponed outside the US. The COVID-19 pandemic caused temporary delays in the company’s commercial investments.

Regional Analysis

North America is expected to account for the highest market share with 36% of the revenue. The pandemic has ravaged the region. The government took various steps to fight the pandemic.

The pandemic had a positive effect on the market. FDA issued first-of-its-kind emergency authorization for a respiratory stimulator device to assist in the weaning of COVID-19 patients from ventilators.

North America is expected to hold a significant market share, due to its growing healthcare spending and development of medical devices and increasing musculoskeletal diseases, and well-established healthcare infrastructure.

According to the Arthritis Society of America, approximately 20% of the Canadian population (that is, 1 in 5) will suffer from arthritis in 2021. Pain affects more Americans than diabetes, heart disease, and cancer combined. It is the number one reason that Americans don’t have access to the healthcare system because of pain. It is the leading cause of disability and a major contributor to healthcare costs. Additionally, the region has a competitive edge due to the launch of new products.

De Novo approval was granted to Innovative Health Solutions in June 2019 for a prescription nerve stimulation system, the IB Stim device. This single-use electrical nerve stimulator is designed to reduce functional abdominal pain.

The device can be used by adolescents and teenagers with irritable stool syndrome in combination with other therapies. The Asia Pacific will be the fastest-growing region in the forecast period. The key growth stimulants for the region are growing awareness about health and fitness, increased use of pain management therapies, and increasing usage of smart devices to maintain health. In the future, the region will see an increase in sports injuries.

Key Regions and Countries Covered in this Report:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Spain
  • Rest of Europe

• APAC
  • China
  • Japan
  • South Korea
  • India
  • Rest of Asia-Pacific
• South America
  • Brazil
  •  Argentina
  •  Rest of South America
• Middle East Africa
  • GCC
  •  South Africa
  •  Israel
  •  Rest of Middle East Africa

Market Share & Key Players Analysis:

Market participants are actively involved in expanding the variety of muscle stimulator and their applications. Some of the major players in this market are:

• AxioBionics LLC
• Beurer GmbH
• BioMedical Life Systems Inc.
• Colfax Corporation
• EMS Physio Ltd.
• Liberate Medical
• OMRON Corporation
• RS Medical
• Zynex Medical
• Other Key Players